International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear.
Osamu Kumano +6 more
wiley +1 more source
Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis. [PDF]
Clin Appl Thromb Hemost, 2023 Yuan Y, Li X, Qiu F.
europepmc +1 more source
Effect of Body Mass Index on Bleeding Frequency and Activated Partial Thromboplastin Time in Weight-Based Dosing of Unfractionated Heparin: A Retrospective Cohort Study [PDF]
, 2009 Seth R. Bauer +6 more
openalex +1 more source
Correlation between Slope 2 in Clot Waveform Analysis of Activated Partial Thromboplastin Time with Factor VIII Activity in Hemophilia A [PDF]
, 2022 Raissa Yolanda +3 more
openalex +1 more source
Prolonged activated partial thromboplastin time predicts poor short-term prognosis in patients with acute pancreatitis: A retrospective cohort study. [PDF]
Clin Transl Sci, 2022 Yang Y, Du S, Yuan W, Kou Y, Nie B.
europepmc +1 more source
Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy: Does the Prothrombin Time Matter? [PDF]
, 2015 Eugene Pearlman +3 more
openalex +1 more source
Nursing in Critical Care, EarlyView.Abstract Background Regional citrate anticoagulation‐continuous renal replacement therapy (RCA‐CRRT) has a wide range of applications in clinical practice, but unplanned downtime due to RCA‐CRRT circuit coagulation is as high as 15.75%–66.70%. Aim To build a nomogram model for predicting the lifespan circuits of RCA‐CRRT.
Zhongbin Chen +14 more
wiley +1 more source